Axovia Therapeutics

About:

Axovia Therapeutics develops transformative therapies targeting critical aspects of ciliopathies.

Website: https://axoviatherapeutics.com

Top Investors: A Race Against Blindness

Description:

Axovia is dedicated to developing disease-transformative therapies that target key aspects of ciliopathies, addressing the devastating impact of the disease head-on for patients, their families, and caregivers. Axovia Therapeutics is advancing its pipeline to deliver innovative treatments for rare genetic disorders, particularly those leading to blindness.

Total Funding Amount:

$1M

Headquarters Location:

London, England, United Kingdom

Founded Date:

1999-01-01

Founders:

Philip Beales, Victor Hernandez

Number of Employees:

11-50

Last Funding Date:

2024-10-30

IPO Status:

Private

Industries:

© 2025 bioDAO.ai